BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 38332914)

  • 1. The 'analysis of gene expression and biomarkers for point-of-care decision support in Sepsis' study; temporal clinical parameter analysis and validation of early diagnostic biomarker signatures for severe inflammation andsepsis-SIRS discrimination.
    Szakmany T; Fitzgerald E; Garlant HN; Whitehouse T; Molnar T; Shah S; Tong DL; Hall JE; Ball GR; Kempsell KE
    Front Immunol; 2023; 14():1308530. PubMed ID: 38332914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Plasma microRNAs can differentiate Human Sepsis and Systemic Inflammatory Response Syndrome (SIRS).
    Caserta S; Kern F; Cohen J; Drage S; Newbury SF; Llewelyn MJ
    Sci Rep; 2016 Jun; 6():28006. PubMed ID: 27320175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of presepsin vs. established biomarkers in critically ill patients with sepsis or systemic inflammatory response syndrome.
    Brodska H; Valenta J; Pelinkova K; Stach Z; Sachl R; Balik M; Zima T; Drabek T
    Clin Chem Lab Med; 2018 Mar; 56(4):658-668. PubMed ID: 29176018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a diagnostic model for early differentiation of sepsis and non-infectious SIRS in critically ill children - a data-driven approach using machine-learning algorithms.
    Lamping F; Jack T; Rübsamen N; Sasse M; Beerbaum P; Mikolajczyk RT; Boehne M; Karch A
    BMC Pediatr; 2018 Mar; 18(1):112. PubMed ID: 29544449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children.
    Wong HR; Cvijanovich NZ; Hall M; Allen GL; Thomas NJ; Freishtat RJ; Anas N; Meyer K; Checchia PA; Lin R; Bigham MT; Sen A; Nowak J; Quasney M; Henricksen JW; Chopra A; Banschbach S; Beckman E; Harmon K; Lahni P; Shanley TP
    Crit Care; 2012 Oct; 16(5):R213. PubMed ID: 23107287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Bioinformatics Framework for Identification and Validation of Genomic Biomarkers and Key Immunopathology Processes and Controllers in Infectious and Non-infectious Severe Inflammatory Response Syndrome.
    Tong DL; Kempsell KE; Szakmany T; Ball G
    Front Immunol; 2020; 11():380. PubMed ID: 32318053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EARLY DIFFERENTIATION BETWEEN SEPSIS AND STERILE INFLAMMATION VIA URINARY GENE SIGNATURES OF METABOLIC DYSREGULATION.
    Bandyopadhyay S; Loftus TJ; Peng YC; Lopez MC; Baker HV; Segal MS; Graim K; Ozrazgat-Baslanti T; Rashidi P; Bihorac A
    Shock; 2022 Jul; 58(1):20-27. PubMed ID: 35904146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts.
    McHugh L; Seldon TA; Brandon RA; Kirk JT; Rapisarda A; Sutherland AJ; Presneill JJ; Venter DJ; Lipman J; Thomas MR; Klein Klouwenberg PM; van Vught L; Scicluna B; Bonten M; Cremer OL; Schultz MJ; van der Poll T; Yager TD; Brandon RB
    PLoS Med; 2015 Dec; 12(12):e1001916. PubMed ID: 26645559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS.
    Lin H; Scull BP; Goldberg BR; Abhyankar HA; Eckstein OE; Zinn DJ; Lubega J; Agrusa J; El Mallawaney N; Gulati N; Forbes L; Chinn I; Chakraborty R; Velasquez J; Goldman J; Bashir D; Lam F; Muscal E; Henry MM; Greenberg JN; Ladisch S; Hermiston ML; Meyer LK; Jeng M; Naqvi A; McClain K; Nguyen T; Wong H; Man TK; Jordan MB; Allen CE
    Blood Adv; 2021 Sep; 5(17):3457-3467. PubMed ID: 34461635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Accuracy of a Host Gene Expression Signature That Discriminates Clinical Severe Sepsis Syndrome and Infection-Negative Systemic Inflammation Among Critically Ill Children.
    Zimmerman JJ; Sullivan E; Yager TD; Cheng C; Permut L; Cermelli S; McHugh L; Sampson D; Seldon T; Brandon RB; Brandon RA
    Crit Care Med; 2017 Apr; 45(4):e418-e425. PubMed ID: 27655322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key Signature Genes of Early Terminal Granulocytic Differentiation Distinguish Sepsis From Systemic Inflammatory Response Syndrome on Intensive Care Unit Admission.
    Velásquez SY; Coulibaly A; Sticht C; Schulte J; Hahn B; Sturm T; Schefzik R; Thiel M; Lindner HA
    Front Immunol; 2022; 13():864835. PubMed ID: 35844509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiles differentiate between sterile SIRS and early sepsis.
    Johnson SB; Lissauer M; Bochicchio GV; Moore R; Cross AS; Scalea TM
    Ann Surg; 2007 Apr; 245(4):611-21. PubMed ID: 17414611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS.
    Mussap M; Puxeddu E; Puddu M; Ottonello G; Coghe F; Comite P; Cibecchini F; Fanos V
    Clin Chim Acta; 2015 Dec; 451(Pt A):65-70. PubMed ID: 26232159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic and prognostic value of procalcitonin and common inflammatory markers combining SOFA score in patients with sepsis in early stage].
    Xing YB; Dai LM; Zhao ZH; Li ZW; Li C
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Jan; 20(1):23-8. PubMed ID: 18199396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for In-Hospital Mortality Among Adults With Suspected Infection Admitted to the Intensive Care Unit.
    Raith EP; Udy AA; Bailey M; McGloughlin S; MacIsaac C; Bellomo R; Pilcher DV;
    JAMA; 2017 Jan; 317(3):290-300. PubMed ID: 28114553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Key Inflammation-related Genes as Potential Diagnostic Biomarkers of Sepsis.
    Guo P; Wang R; Shen J; Zhang L; Mo W
    Altern Ther Health Med; 2023 Jul; 29(5):24-31. PubMed ID: 37235492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of different consensus definition criteria on sepsis diagnosis in a cohort of critically ill patients-Insights from a new mathematical probabilistic approach to mortality-based validation of sepsis criteria.
    Centner FS; Schoettler JJ; Fairley AM; Lindner HA; Schneider-Lindner V; Weiss C; Thiel M; Hagmann M
    PLoS One; 2020; 15(9):e0238548. PubMed ID: 32898161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study.
    Anand D; Das S; Bhargava S; Srivastava LM; Garg A; Tyagi N; Taneja S; Ray S
    J Crit Care; 2015 Feb; 30(1):218.e7-12. PubMed ID: 25263339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis.
    Garnacho-Montero J; Huici-Moreno MJ; Gutiérrez-Pizarraya A; López I; Márquez-Vácaro JA; Macher H; Guerrero JM; Puppo-Moreno A
    Crit Care; 2014 Jun; 18(3):R116. PubMed ID: 24903083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6.
    Selberg O; Hecker H; Martin M; Klos A; Bautsch W; Köhl J
    Crit Care Med; 2000 Aug; 28(8):2793-8. PubMed ID: 10966252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.